Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 205
Aptamer sequence: CTGAGATCTCGGAAT
Target unique ID: P04585
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_201 PF1-15nt5' cut Protein POL_HV1H2 > 750 nM 50 mM Tris-HCl, pH 8, 1mM DTT, 80 mM KCl, 6 mM MgCl2 for ten minutes 22554064
Structure information of aptamer
Aptamer Sequence: CTGAGATCTCGGAAT
The optimal secondary structure in dot-bracket notation: ((((....))))...
The centroid secondary structure in dot-bracket notation: ((((....))))...
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_201 Description PF1-15nt5' cut
Aptamer chemistry DNA Length 15 nt
GC content 46.7% Molecular weight 4,831.94 Da
Molarity of 1 μg/μl solution 206.96 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted therapy
Sequence CTGAGATCTCGGAAT
Applications Inhibiting function against the WT HIV-1 RT
Target information
Type Detail Type Detail
Uniprot ID P04585 Protein name Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
Gene name(s) gag-pol Organism Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
Status reviewed in uniprot database Length 1435
Mass 162,042 Activity regulation The viral protease is inhibited by many synthetic protease inhibitors (PIs), such as amprenavir, atazanavir, indinavir, loprinavir, nelfinavir, ritonavir and saquinavir
Involvement in disease N/A Catalytic activity Reaction=Specific for a P1 residue that is hydrophobic, and P1' variable
PDB ID(s)
1A30;1BV7;1BV9;1BVE;1BVG;1BWA;1BWB;1C0T;1C0U;1C1B;1C1C;1DMP;1DTQ;1DTT;1E6J;1EP4;1ESK;1EX4;1EXQ;1FB7;1FK9;1FKO;1FKP;1G6L;1HIV;1HVH;1HVR;1HWR;1HXB;1JKH;1JLA;1JLB;1JLC;1JLE;1JLF;1JLG;1JLQ;1KLM;1LV1;1LW0;1LW2;1LWC;1LWE;1LWF;1NCP;1O1W;1ODW;1ODY;1QBR;1QBS;1QBT;1QBU;1REV;1RT1;1RT2;1RT3;1RT4;1RT5;1RT6;1RT7;1RTD;1RTH;1RTI;1RTJ;1S1T;1S1U;1S1V;1S1W;1S1X;1T05;1TAM;1TKT;1TKX;1TKZ;1TL1;1TL3;1VRT;1VRU;2HND;2HNY;2HNZ;2KOD;2NPH;2OPP;2OPQ;2OPR;2OPS;2RF2;2RKI;2WHH;2WOM;2WON;2YNF;2YNG;2YNH;2YNI;3AO2;3C6T;3C6U;3DI6;3DLE;3DLG;3DM2;3DMJ;3DOK;3DOL;3DOX;3DRP;3DRR;3DRS;3DYA;3E01;3FFI;3I0R;3I0S;3KJV;3KK1;3KK2;3KK3;3KT2;3KT5;3LAK;3LAL;3LAM;3LAN;3LP0;3LP1;3LP2;3M8P;3M8Q;3MEC;3MED;3MEE;3MEG;3N3I;3NBP;3PHV;3QIN;3QIO;3QIP;3T19;3T1A;3TAM;4B3O;4B3P;4B3Q;4I7F;4KSE;4KV8;4NCG;4Q1W;4Q1X;4Q1Y;4Q5M;4QLH;4U1H;4U1I;4U1J;4U7Q;4U7V;5DGU;5DGW;5EU7;5HRN;5HRP;5HRR;5HRS;5IM7;5J2M;5J2N;5J2P;5J2Q;5K14;5KAO;5T82;5TC2;5VZ6;5XOS;5XOT;5YRS;6BJ2;6BJ3;6BSG;6BSH;6BSI;6BSJ;6DIF;6DIL;6DJ1;6DJ2;6DJ5;6DJ7;6DV0;6DV4;6E7J;6E9A;6EWA;6EX9;6GL1;6J1V;6J1W;6OR7;6OTZ;6P1I;6P1X;6P2G;6PYL;6SKK;6SKM;6SKN;6SLQ;6SLU;6SMU;6UIR;6UIS;6UIT;6UJX;6UJY;6UJZ;6UK0;6VPZ;6VQ2;6VQD;6VQE;6VQY;6VQZ;6WAZ;6WB1;6WPF;6WPH;6WPJ;
Function Mediates, with Gag polyprotein, the essential events in virion assembly, including binding the plasma membrane.
Activity data

No relevant experimental diagram

Interaction ID 205
Target type Protein
Target unique ID P04585
Activity > 750 nM
Binding Conditions/Buffer

50 mM Tris-HCl, pH 8, 1mM DTT, 80 mM KCl, 6 mM MgCl2 for ten minutes

Assay

N/A

PubMed ID 22554064
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_199 DNA TAGGTCTGAGATCTCGGAAT 75.00%
Apta_197 DNA GGCTTTAGGTCTGAGATCTCGGAAT 60.00%
Apta_206 DNA AGGAAGGGGTCTGAGATCTCGGAAT 60.00%
Apta_202 DNA AAGGCTTTAGGTCTGAGATCTCGGAAT 55.56%
Apta_208 DNA AGGAAGGGGTGGAAT 53.33%
Apta_1145 DNA ACTGCTAGAGATTTTCCACAT 52.38%
Apta_184 DNA AGGAAGGCTTTAGGTCTGAGATCTCGGAAT 50.00%
Apta_186 DNA AGGAACGCTTTAGGTCTGAGATCTCGGAAT 50.00%
Apta_189 DNA AGGAACCCTTTACCTCTGAGATCTCGGAAT 50.00%
Apta_190 DNA AGGAACCCTTTAGGTCTGAGATCTCGGAAT 50.00%
Apta_191 DNA AGGAAGGCTTTACCTCTGAGATCTCGGAAT 50.00%
Apta_192 DNA AGGAAGGCTTTAGCTCTGAGATCTCGGAAT 50.00%
Apta_207 DNA AGGAAGGCTTTAGGTGGAAT 50.00%
Apta_210 DNA AGGTTGGTTGGTTGGAAT 50.00%
Apta_215 DNA AGGAAGGCTTTAGGTCCGAGATCTCGGAAT 50.00%
Apta_538 DNA GTGTTGTCTCTCTGTGTCTC 50.00%
Apta_539 DNA CGTGTTGTCTCTCTGTGTCTCG 50.00%
Apta_1158 DNA CCAGTACAAGGTGCTAAACGTAAT 50.00%
Apta_1160 DNA TTCAGTATCCCACGGGTGGAATCA 50.00%
Apta_193 DNA AGGAAGGCTTTAGGGTCTGAGATCTCGGAAT 48.39%